NAGE
Price:
$6.7
Market Cap:
$534.70M
Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.
Industry
Biotechnology
IPO Date
2015-06-24
Stock Exchange
NASDAQ
Ticker
NAGE
According to Niagen Bioscience Inc’s latest financial reports and current stock price. The company's current PE Ratio is 27.92. This represents a change of -32.51% compared to the average of 41.37 of the last 4 quarters.
The mean historical PE Ratio of Niagen Bioscience Inc over the last ten years is -12.61. The current 27.92 PE Ratio has changed -22241.65% with respect to the historical average. Over the past ten years (40 quarters), NAGE's PE Ratio was at its highest in in the December 2023 quarter at 228.57. The PE Ratio was at its lowest in in the September 2015 quarter at -8023.52.
Average
-12.61
Median
-11.99
Minimum
-47.39
Maximum
53.05
Discovering the peaks and valleys of Niagen Bioscience Inc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 191.84%
Maximum Annual PE Ratio = 53.05
Minimum Annual Increase = -359.69%
Minimum Annual PE Ratio = -47.39
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 53.05 | -359.69% |
| 2023 | -20.43 | 191.84% |
| 2022 | -7.00 | -24.43% |
| 2021 | -9.26 | -37.04% |
| 2020 | -14.71 | 92.31% |
| 2019 | -7.65 | 35.08% |
| 2018 | -5.66 | -77.25% |
| 2017 | -24.89 | -40.96% |
| 2016 | -42.16 | -11.04% |
| 2015 | -47.39 | 172.54% |
The current PE Ratio of Niagen Bioscience Inc (NAGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.54
5-year avg
0.33
10-year avg
-12.61
Niagen Bioscience Inc’s PE Ratio is greater than Olema Pharmaceuticals, Inc. (-15.80), greater than Corvus Pharmaceuticals, Inc. (-48.41), greater than Prothena Corporation plc (-2.14), greater than Ventyx Biosciences, Inc. (-5.35), greater than Keros Therapeutics, Inc. (12.78), greater than Akebia Therapeutics, Inc. (-26.47), greater than Rigel Pharmaceuticals, Inc. (7.54), less than Zevra Therapeutics, Inc. (179.43), greater than REGENXBIO Inc. (-3.77), greater than KalVista Pharmaceuticals, Inc. (-4.32),
| Company | PE Ratio | Market cap |
|---|---|---|
| -15.80 | $1.90B | |
| -48.41 | $657.64M | |
| -2.14 | $600.74M | |
| -5.35 | $570.87M | |
| 12.78 | $821.72M | |
| -26.47 | $421.93M | |
| 7.54 | $845.55M | |
| 179.43 | $487.51M | |
| -3.77 | $657.04M | |
| -4.32 | $828.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Niagen Bioscience Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Niagen Bioscience Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Niagen Bioscience Inc's PE Ratio?
How is the PE Ratio calculated for Niagen Bioscience Inc (NAGE)?
What is the highest PE Ratio for Niagen Bioscience Inc (NAGE)?
What is the 3-year average PE Ratio for Niagen Bioscience Inc (NAGE)?
What is the 5-year average PE Ratio for Niagen Bioscience Inc (NAGE)?
How does the current PE Ratio for Niagen Bioscience Inc (NAGE) compare to its historical average?